These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25403279)

  • 1. [The role of angiogenic factors in preeclampsia].
    Alasztics B; Gullai N; Molvarec A; Rigó J
    Orv Hetil; 2014 Nov; 155(47):1860-6. PubMed ID: 25403279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.
    Unal ER; Robinson CJ; Johnson DD; Chang EY
    Am J Obstet Gynecol; 2007 Aug; 197(2):211.e1-4. PubMed ID: 17689655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.
    Lam C; Lim KH; Karumanchi SA
    Hypertension; 2005 Nov; 46(5):1077-85. PubMed ID: 16230516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vascular endothelial growth factor family in adverse pregnancy outcomes.
    Andraweera PH; Dekker GA; Roberts CT
    Hum Reprod Update; 2012 Jul; 18(4):436-57. PubMed ID: 22495259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application.
    Lapaire O; Shennan A; Stepan H
    Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):122-9. PubMed ID: 20457483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.
    Crispi F; Domínguez C; Llurba E; Martín-Gallán P; Cabero L; Gratacós E
    Am J Obstet Gynecol; 2006 Jul; 195(1):201-7. PubMed ID: 16545329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.
    Pinheiro CC; Rayol P; Gozzani L; Reis LM; Zampieri G; Dias CB; Woronik V
    Prenat Diagn; 2014 Nov; 34(11):1084-92. PubMed ID: 24916790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays.
    Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
    Am J Obstet Gynecol; 2011 Nov; 205(5):469.e1-8. PubMed ID: 21903191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic factors for the prediction of preeclampsia in high-risk women.
    Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
    Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentrations of antiangiogenic factors, triglycerides, glucose and insulin in women with two types of preeclampsia].
    Kornacki J; Wirstlein P; Skrzypczak J
    Ginekol Pol; 2013 Sep; 84(9):770-5. PubMed ID: 24191515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic and Antiangiogenic Markers for Prediction and Risk Classification of Preeclampsia.
    Malshe AK; Sibai BM
    Clin Obstet Gynecol; 2017 Mar; 60(1):134-140. PubMed ID: 28059847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion.
    Stepan H; Unversucht A; Wessel N; Faber R
    Hypertension; 2007 Apr; 49(4):818-24. PubMed ID: 17261644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
    Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
    Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
    Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
    Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.
    Woodham PC; Brittain JE; Baker AM; Long DL; Haeri S; Camargo CA; Boggess KA; Stuebe AM
    Hypertension; 2011 Dec; 58(6):1120-5. PubMed ID: 21986503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.